NO983540L - Farmas°ytiske preparater inneholdende cilansetron som er stabilisert mot racemisering - Google Patents

Farmas°ytiske preparater inneholdende cilansetron som er stabilisert mot racemisering

Info

Publication number
NO983540L
NO983540L NO983540A NO983540A NO983540L NO 983540 L NO983540 L NO 983540L NO 983540 A NO983540 A NO 983540A NO 983540 A NO983540 A NO 983540A NO 983540 L NO983540 L NO 983540L
Authority
NO
Norway
Prior art keywords
pharmaceutical preparations
preparations containing
stabilized against
against racemization
cilansetron
Prior art date
Application number
NO983540A
Other languages
English (en)
Other versions
NO983540D0 (no
NO323229B1 (no
Inventor
Ingo Bonnacker
Hartmut Koehn
Gerhard Kristen
Christine Reichel
Original Assignee
Solvay Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh
Publication of NO983540D0 publication Critical patent/NO983540D0/no
Publication of NO983540L publication Critical patent/NO983540L/no
Publication of NO323229B1 publication Critical patent/NO323229B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO19983540A 1997-08-01 1998-07-31 Flytende eller faste farmasoytiske preparater inneholdende cilansetron stabilisert mot racemisering, anvendelse av sure tilsetningsstoffer til stabiliseringen og fremgangsmate for fremstilling av slike faste preparater NO323229B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19733271 1997-08-01
DE19813661A DE19813661A1 (de) 1997-08-01 1998-03-27 Gegen Racemisierung stabilisierte pharmazeutische Zubereitungen von Cilansetron

Publications (3)

Publication Number Publication Date
NO983540D0 NO983540D0 (no) 1998-07-31
NO983540L true NO983540L (no) 1999-02-02
NO323229B1 NO323229B1 (no) 2007-02-05

Family

ID=7837672

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19983540A NO323229B1 (no) 1997-08-01 1998-07-31 Flytende eller faste farmasoytiske preparater inneholdende cilansetron stabilisert mot racemisering, anvendelse av sure tilsetningsstoffer til stabiliseringen og fremgangsmate for fremstilling av slike faste preparater

Country Status (28)

Country Link
US (1) US5977127A (no)
EP (1) EP0895782B1 (no)
JP (1) JP4324260B2 (no)
KR (1) KR100515201B1 (no)
CN (1) CN1117565C (no)
AR (1) AR010178A1 (no)
AT (1) ATE283706T1 (no)
AU (1) AU743043B2 (no)
BR (1) BR9803730A (no)
CA (1) CA2244389C (no)
CZ (1) CZ295072B6 (no)
DE (2) DE19813661A1 (no)
DK (1) DK0895782T3 (no)
DZ (1) DZ2560A1 (no)
ES (1) ES2234051T3 (no)
HU (1) HUP9801712A3 (no)
ID (1) ID20685A (no)
IL (1) IL125403A (no)
NO (1) NO323229B1 (no)
NZ (1) NZ331083A (no)
PL (1) PL191767B1 (no)
PT (1) PT895782E (no)
RU (1) RU2199318C2 (no)
SK (1) SK284916B6 (no)
TR (1) TR199801432A3 (no)
TW (1) TW509570B (no)
UA (1) UA62924C2 (no)
ZA (1) ZA986715B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7452545B2 (en) * 2001-11-13 2008-11-18 Yu Ruey J Oligosaccharide aldonic acids and their topical use
WO2002076432A2 (en) * 2001-03-26 2002-10-03 Novartis Ag Pharmaceutical composition comprising a poorly water-soluble active ingredient, a surfactant and a water-soluble polymer
GB0216027D0 (en) * 2002-07-10 2002-08-21 Arachnova Therapeutics Ltd New therapeutic use
US20040048874A1 (en) * 2001-05-22 2004-03-11 Bardsley Hazel Judith New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D]pyrimidine
KR20050111318A (ko) * 2003-01-13 2005-11-24 다이노젠 파마세우티컬스, 인코포레이티드 기능성 장 질환을 치료하는 방법
ES2285407T3 (es) * 2003-01-13 2007-11-16 Dynogen Pharmaceuticals Inc. Metodo para el tratamiento de nauseas, vomitos, arcadas o cualquiera de sus combinaciones.
CA2519379A1 (en) * 2003-04-04 2004-10-21 Dynogen Pharmaceuticals, Inc. Method of treating lower urinary tract disorders
US7820690B2 (en) * 2004-03-19 2010-10-26 Solvay Pharmaceuticals Gmbh Method of treating or inhibiting a non-digestive tract derived abdominal disorder associated with pain using a 5-HT, receptor antagonist
WO2006105117A2 (en) * 2005-03-28 2006-10-05 Dynogen Pharmaceuticals, Inc. Method of treating disorders and conditions using peripherally-restricted antagonists and inhibitors
US20110152342A1 (en) * 2008-08-14 2011-06-23 Hiroshi Uchida Stabilized pharmaceutical composition
WO2021100728A1 (ja) 2019-11-20 2021-05-27 塩野義製薬株式会社 ６，７－不飽和－７－カルバモイルモルヒナン誘導体含有固形製剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3885357T2 (de) * 1987-06-29 1994-03-24 Duphar Int Res Anellierte Indolderivate.
DE4238553A1 (de) * 1992-11-14 1994-05-19 Kali Chemie Pharma Gmbh Neue Imidazol-1-yl-Verbindungen enthaltende Arzneimittel
AU702594B2 (en) * 1995-10-13 1999-02-25 Duphar International Research B.V. Process for the preparation of enantiomerically pure imidazolyl compounds

Also Published As

Publication number Publication date
ID20685A (id) 1999-02-18
CZ236798A3 (cs) 1999-02-17
HUP9801712A2 (hu) 1999-04-28
TR199801432A2 (xx) 1999-02-22
KR19990023194A (ko) 1999-03-25
DK0895782T3 (da) 2005-01-03
CA2244389C (en) 2008-01-15
NZ331083A (en) 2000-01-28
DE59812317D1 (de) 2005-01-05
CN1207292A (zh) 1999-02-10
TR199801432A3 (tr) 1999-02-22
HUP9801712A3 (en) 2001-08-28
UA62924C2 (en) 2004-01-15
HK1017611A1 (en) 1999-11-26
ZA986715B (en) 1999-02-04
IL125403A (en) 2001-11-25
TW509570B (en) 2002-11-11
CZ295072B6 (cs) 2005-05-18
EP0895782A2 (de) 1999-02-10
US5977127A (en) 1999-11-02
CN1117565C (zh) 2003-08-13
AR010178A1 (es) 2000-05-17
BR9803730A (pt) 2000-03-28
EP0895782B1 (de) 2004-12-01
JP4324260B2 (ja) 2009-09-02
DE19813661A1 (de) 1999-02-04
JPH1192369A (ja) 1999-04-06
AU7863098A (en) 1999-02-11
NO983540D0 (no) 1998-07-31
SK100998A3 (en) 1999-02-11
KR100515201B1 (ko) 2005-12-09
RU2199318C2 (ru) 2003-02-27
PT895782E (pt) 2005-02-28
PL327786A1 (en) 1999-02-15
DZ2560A1 (fr) 2003-02-15
NO323229B1 (no) 2007-02-05
HU9801712D0 (en) 1998-09-28
IL125403A0 (en) 1999-03-12
ES2234051T3 (es) 2005-06-16
CA2244389A1 (en) 1999-02-01
ATE283706T1 (de) 2004-12-15
AU743043B2 (en) 2002-01-17
PL191767B1 (pl) 2006-06-30
SK284916B6 (sk) 2006-02-02
EP0895782A3 (de) 2001-01-31

Similar Documents

Publication Publication Date Title
DE69814091D1 (de) Voriconazol-enthaltende pharmazeutische zubereitungen
DE69831620D1 (de) Arzneizubereitungen enthaltend Kannabinoide
NO20001371L (no) Farmasøytiske preparater inneholdende plasmaprotein
DK114797A (da) Farmaceutiske præparater til intranasal administrering
NO965377D0 (no) Indolinonforbindelser samt farmasöytiske preparater inneholdende forbindelsene
IS5058A (is) Samverkandi súlfónýlþvagefnis-glitasónsblöndur við sykursýki
ID24654A (id) Formulasi farmasi omeprazola
DK0998272T3 (da) Farmaceutisk præparat til kombinationen piperidinoalkanoldekongestivum
DE122010000011I1 (de) Flüssige gonadotropinhaltige Arzneimittel
IS5953A (is) Lyfjablöndur úr örgerðum eplerenonum
DK0921796T3 (da) Tetrahydrolipstatinholdige præparater
FI961437A0 (fi) Vaikuttavan aineen luovuttava systeemi
DK0868911T3 (da) Rapamycinpræparater til oral indgivelse
NO983540D0 (no) Farmas°ytiske preparater av cilansetron som er stabilisert mot racemisering
FI955968A7 (fi) Annostelija kiinteitä lääkeaineita varten
EE9800275A (et) Misolastiini sisaldavad prolongeeritud toimega farmatseutilised preparaadid
DK1041966T3 (da) Farmaceutiske præparater omfattende zafirlukast
DE69811367D1 (de) Cis-substituierte fluoromethylpyrrolidin-derivate
NO995653L (no) Cis-substituerte aminocykloalkyl-pyrrolidin-derivater
FI973230A7 (fi) Uusi farmaseuttinen formulaatio
DE69906934D1 (de) Arzneizubereitungen
FI931918A7 (fi) Transportanordning foer en balk som skall foerflyttas i laengsriktningen
NO20002321D0 (no) Bifenylderivater som farmasøytiske midler
NO965448D0 (no) Farmasöytiske forbindelser
FI962725A0 (fi) Farmaseuttisia formulaatioita, jotka käsittävät polytioureaa sekä menetelmä niiden käyttämiseksi

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees